page_title: Undurti Narasimha Das
section_title: Legacy
hierarchical_section_title: Undurti Narasimha Das / Legacy
caption_attribution_description: English: Two MRI images of my brain (rear view on left, top view on right) showing a low grade, encapsulated cyst-like glioma (or multiple gliomas). Image was created on July 10, 2007. Any expert information and opinions are appreciated.
context_page_description: Undurti Narasimha Das is an Indian clinical immunologist, endocrinologist and the founder president and chief executive officer of UND Life Sciences. An elected fellow of the National Academy of Medical Sciences, Das is known for his researches in the fields of Immunology, Endocrinology and Rheumatology. He holds a number of patents for his work The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 1992.
context_section_description: Researches of U. N. Das are focused on various disease processes and his researches have revealed the tumoricidal properties of cis-unsaturated fatty acids as well as the role of gamma-Linolenic acid in controlling the progress of glioma, a type of tumor which affects brain and spinal cord. He has also worked on drug development to combat diseases and conditions such as obesity, cancer, diabetes, hypertension and schizophrenia. His researches have been documented by way of several articles; ResearchGate an online repository of scientific articles has listed 500 of them. Besides, he has authored three books, viz. Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids, Molecular Basis of Health and Disease and A Perinatal Strategy For Preventing Adult Disease: The Role of Long-Chain Polyunsaturated Fatty Acids. He holds a number of patents for his work, which include "Method of potentiating the action of 2-methoxyoestradiol, statins and C-peptide of proinsulin, Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF) Method of stabilizing and potentiating the action of anti-angiogenic substances, Method(s) of preventing, arresting, reversing and treatment of atherosclerosis, and Methods for selectively occluding blood supplies to neoplasias and Butyrylcholinesterase as a marker of low-grade systemic inflammation.
  Das is the editor-in-chief of Lipids in Health and Disease, a journal published by BioMed Central and Current Nutrition & Food Science, published by Bentham Science. He is the section editor of Medicine journal, a member of the editorial board of the controversial and non-peer reviewed journal Medical Hypotheses and the Journal of Geriatric Cardiology and sits in the scientific advisory board of Techno Scienze Publisher which publishes a number of journals. He is also a member of the editorial review board of Journal of Applied Research in Clinical and Experimental Therapeutics and has been associated with a number of other journals as a member of their editorial boards or the Panel of Reviewers which include World Journal of Diabetes, European Journal of General Medicine, Journal of the Association of Physicians of India, Frontiers in Biosciences, Diabetes Review Letters, Open Colorectal Cancer Journal, Indian Journal of Medical Research and Gene Therapy and Molecular Biology. He has also been a member of the International Advisory Board of the II International Conference on Functional Foods for the Prevention and Treatment of Chronic Diseases, organized by Functional Foods Center, held in November, 2005 at Richardson, Texas;
caption: Glioma – MRI
exif: {}